Susanne Arnold

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Susanne Arnold sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).

8 total trials none currently recruiting 4 completed early-phase tilt upper quartile by trial count

Susanne Arnold: 8 sponsored US clinical trials, none currently recruiting.

Susanne Arnold sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stage IIIB Non-small Cell Lung Cancer, with 1 trials.

Upper-quartile sponsor footprint

Susanne Arnold sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

8 total, page 1 of 1

ACTIVE NOT RECRUITING Phase 2

Cisplatin + Radiation in SCCHN and Correlation With Oxidative Stress Markers

NCT02994069
TERMINATED Phase 2

Novel Agents for Treatment of High-risk COVID-19 Positive Patients

NCT04374019
COMPLETED Phase 2

A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN

NCT02126969
COMPLETED

Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens

NCT01648166
TERMINATED Phase 1

Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

NCT00176241
COMPLETED Phase 2

Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer

NCT00247416
COMPLETED NA

Early Detection of Lung Cancer in a High-Risk Population Defined by PFT, Biomarkers, and CT Scanning

NCT00596310
TERMINATED Phase 1

Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC

NCT00378404

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 4

Therapeutic Areas

Stage IIIB Non-small Cell Lung Cancer 1
Stage IV Non-small Cell Lung Cancer 1
Carcinoma, Squamous Cell 1
Lung Cancer 1
Head and Neck Cancer 1

How the Susanne Arnold early-phase archive is shaped

8 indexed studies, none listed as recruiting (0% open); 4 completed (50%).

Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Stage IIIB Non-small Cell Lung Cancer (1 trial), 4 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Susanne Arnold: archived-pipeline peers nationwide

Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Susanne Arnold sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40% Total trials Recruiting share Susanne ArnoldAB ScienceAbbott Point of CareAbeona TherapeuticsAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10xBio22nd Century Group23andMe3-C Institute for Social Development
Susanne Arnold sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Susanne Arnold sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 8 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Susanne Arnold page

8 registered trials is a research-attention snapshot, not an endorsement of Susanne Arnold or any single study.

  • None of Susanne Arnold's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Stage IIIB Non-small Cell Lung Cancer is the condition Susanne Arnold studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stage IIIB Non-small Cell Lung Cancer trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Susanne Arnold pipeline card: 8 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.